Close sidebar

Transcranial Pulse Stimulation (TPS®) in Alzheimer’s Disease

TPS® method of action

Destructive protein molecules (so-called plaques) disrupt the function of neurons and cause a reduction of cerebral blood flow. This leads to disruptions of the oxygen and energy supply of the brain. The stimulation of growth factors, primarily VEGF, not only improves cerebral blood flow, but also promotes the formation of new blood vessels (angiogenesis) and nerve regeneration. The release of nitric oxide (NO) leads to direct vasodilation and improved blood circulation.

Study results: TPS® significantly improves brain performance

Since then, more than 1500 treatments have been performed. There are no known side effects. In 2019, the first treatment results were published in the prestigious journal »Advanced Science«. In the pilot study, the CERAD score significantly improved after TPS® treatment. The improvements lasted for 3 months after the completion of the treatment series. A longer lasting therapeutic success can be expected according to current treatment results. Click the Learn More link below for references.

Learn More

TPS® treatment: effective and safe

TPS® can stimulate deep cerebral regions, reaching as much as 8 cm into the brain. Owing to the short duration of the TPS® stimulation, tissue heating is avoided. The patient is not immobilized during the treatment and able to move freely.

The TPS® advantages:

Documented effectiveness: TPS® treatment has been shown to significantly improve CERAD test performance and to reduce Beck’s depression index in patients with mild to moderate dementia.

The NEUROLITH® system: ergonomic and precise

The ergonomic shape of the handpiece minimizes hand fatigue to facilitate treatment working directly on the patient and the coupling surface adapts easily to any shape of head. The NEUROLITH® software includes patient management functionalities with retrievable data and recommended treatment parameters.

Advantages of the NEUROLITH® system:

Learn More